Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Lifestyle Health and Longevity

Doctors and Patients Struggle With Trust Amid a Broken Healthcare System

by Team Lumida
March 23, 2025
in Health and Longevity
Reading Time: 4 mins read
A A
0
person sitting while using laptop computer and green stethoscope near

Photo by National Cancer Institute on Unsplash

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • Trust between doctors and patients is eroding, with both sides frustrated by systemic issues like rushed appointments, corporate quotas, and communication breakdowns.
  • Doctors cite loss of autonomy and patient dishonesty as key challenges, while patients feel unheard and constrained by limited time with physicians.
  • Unrealistic expectations and reliance on online medical advice further strain the doctor-patient relationship.
  • Solutions include better communication, shared decision-making, and mutual respect to rebuild trust in the short term.

What Happened?

The U.S. healthcare system is leaving both doctors and patients frustrated, with trust between the two groups increasingly strained. Doctors report feeling constrained by corporate-imposed patient quotas and excessive documentation requirements, which limit their ability to provide personalized care. Patients, on the other hand, feel rushed and unheard during appointments, leading to dissatisfaction and mistrust.

Doctors also face challenges with patient honesty, as some withhold critical information about their symptoms, lifestyle, or adherence to treatment plans. Unrealistic expectations from patients, such as immediate diagnoses or simple solutions, further complicate the relationship. Meanwhile, the rise of online medical advice has created adversarial dynamics, with patients questioning doctors’ expertise based on internet searches.


Why It Matters?

The fraying trust between doctors and patients reflects deeper systemic issues in the U.S. healthcare system, including the corporatization of medical practices and the prioritization of efficiency over quality care. For doctors, the loss of autonomy and increasing administrative burdens are leading to burnout, while patients feel alienated and underserved.

This erosion of trust has significant implications for healthcare outcomes. Patients who don’t trust their doctors are less likely to follow treatment plans, which can delay recovery and worsen health conditions. For healthcare providers, strained relationships with patients can lead to lower satisfaction scores and reduced effectiveness in delivering care.

For investors and stakeholders in the healthcare industry, these dynamics highlight the need for innovation in patient care models, such as direct primary care practices, which allow for more time and personalized attention. Addressing these trust issues is critical for improving patient outcomes and maintaining the credibility of the healthcare system.


What’s Next?

Rebuilding trust will require efforts from both doctors and patients. Doctors can focus on improving communication by giving patients their full attention, engaging in shared decision-making, and meeting patients where they are in their health journeys. Patients, in turn, can prepare for appointments by prioritizing their concerns and being honest about their symptoms and adherence to treatments.

Systemic changes, such as reducing corporate-imposed quotas and allowing doctors more autonomy, will also be necessary to address the root causes of frustration. In the meantime, practices like direct primary care, which prioritize patient-doctor relationships, may offer a model for improving trust and satisfaction.

Ultimately, trust is a two-way street, and both sides must work together to bridge the gap and navigate the challenges of a complex healthcare system.

Source
Previous Post

Micron Stock Drops Despite Strong Earnings as Lower Profit Margins Raise Concerns

Next Post

Trump’s “Liberation Day” Tariffs: A Targeted Trade Strategy with Global Implications

Recommended For You

America’s Protein Obsession Fuels a Booming Market, But Experts Are Concerned

by Team Lumida
1 month ago
black magnifying glass on white and brown marble table

Key Takeaways: Powered by lumidawealth.com Americans are consuming protein in unprecedented ways, with food companies introducing protein-infused products like chips, candy, coffee, and even water. The trend is driven...

Read more

Is Covid Accelerating Cognitive Decline? Long-Covid Patients Face Alarming Risks

by Team Lumida
2 months ago
Pandemic Aftershocks: Why Illnesses Are Surging Worldwide

Key Takeaways: Powered by lumidawealth.com Millions of long-Covid patients continue to experience cognitive difficulties, with some being diagnosed with mild cognitive impairment (MCI), a condition that can precede dementia...

Read more

Emerging Drugs from Lilly, Amgen, and Novartis Target Untreatable Cholesterol Linked to Heart Disease

by Team Lumida
2 months ago
white and blue medication pill blister pack

Key Takeaways: Powered by lumidawealth.com Lipoprotein(a), a genetic cholesterol variant untreatable by statins, increases the risk of heart attacks and strokes by 2-3 times for 1-2 billion people worldwide....

Read more

U.S. Drug Overdose Deaths Decline by 25%, Marking Progress in the Fentanyl Crisis

by Team Lumida
2 months ago
round white pills

Key Takeaways: Powered by lumidawealth.com Overdose deaths in the U.S. dropped by 25% in the 12 months ending October 2024, with 82,000 fatalities reported. The decline is largely driven...

Read more

Retirement Health Worries: Navigating Dementia and Heart Risks in the Golden Years

by Team Lumida
3 months ago
woman in purple polo shirt wearing eyeglasses

Key Takeaways: Powered by lumidawealth.com Retirement often brings increased focus on health concerns, including cognitive decline and heart disease. Family history plays a significant role in health risks, prompting...

Read more

CVS Bets on Pharmacy-First Strategy with Smaller, Streamlined Stores

by Team Lumida
3 months ago
CVS Bets on Pharmacy-First Strategy with Smaller, Streamlined Stores

Key Takeaways: Powered by lumidawealth.com CVS is launching 12 smaller stores focused on pharmacy services, cutting back on traditional retail offerings. The move reflects a response to declining retail...

Read more

TreeHouse Foods Faces Slowdown as Shoppers Cut Back on Even Cheaper Groceries

by Team Lumida
3 months ago
high-angle photography of grocery display gondola

Key Takeaways Powered by lumidawealth.com TreeHouse Foods, a major supplier of private-label goods for retailers like Walmart and Target, is experiencing slower sales growth as inflation-weary consumers reduce spending...

Read more

Mixue Overtakes McDonald’s as the World’s Largest Food Chain by Locations

by Team Lumida
3 months ago
a mcdonald's sign with a cloudy sky in the background

Key Takeaways: Powered by lumidawealth.com Mixue Ice Cream and Tea now operates 45,000 stores globally, surpassing McDonald’s and Starbucks in total locations. The Chinese chain’s low-cost model, with products...

Read more

401(k) Millionaires Surge 27% in 2024 Amid Market Gains and Higher Savings

by Team Lumida
3 months ago
401(k) Millionaires Surge 27% in 2024 Amid Market Gains and Higher Savings

Key Takeaways: Powered by lumidawealth.com The number of 401(k) millionaires rose 27% in 2024, reaching 537,000, driven by strong market performance and increased contribution rates. Average 401(k) and IRA...

Read more

AstraZeneca’s Breast Cancer Drug Camizestrant Shows Promising Late-Stage Trial Results

by Team Lumida
3 months ago
person holding white and orange plastic bottle

Key Takeaways: Powered by lumidawealth.com AstraZeneca’s experimental breast cancer drug, Camizestrant, demonstrated significant improvement in progression-free survival compared to standard treatments in a late-stage trial. The drug, combined with...

Read more
Next Post
Tech Titans Pivot: Silicon Valley’s New Alliance in Trump’s Second Term

Trump’s “Liberation Day” Tariffs: A Targeted Trade Strategy with Global Implications

Trump Eyes Ukraine’s Metals, but Mining Them Comes with High Costs and Risks

Trump Proposes Aid-for-Minerals Deal with Ukraine Amid War Challenges

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

UniCredit to Double Stake in Greek Bank Alpha Services to 20%, Adding €180 Million in Annual Profit

UniCredit to Double Stake in Greek Bank Alpha Services to 20%, Adding €180 Million in Annual Profit

May 28, 2025
red green and yellow flag

Portugal’s Government Faces Collapse Amid Scandal and Confidence Vote

March 11, 2025
white and green hard disk drive

AMD Enters Healthcare AI Race with $20M Absci Investment, Challenging Nvidia’s Dominance

January 8, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018